Corbus Pharmaceuticals Holdings, Inc.
CRBP
$8.94
-$0.11-1.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -115.69% | -69.35% | -76.67% | -146.09% | -18.80% |
| Total Depreciation and Amortization | -63.43% | -67.11% | -64.67% | -46.71% | -9.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -25.30% | -3.78% | 212.68% | 1,792.31% | 46.14% |
| Change in Net Operating Assets | 250.39% | 403.90% | -75.00% | 32.71% | -357.84% |
| Cash from Operations | -45.50% | -11.53% | -85.61% | -106.11% | -82.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -754.50% | 227.81% | 207.93% | 118.45% | -15.96% |
| Cash from Investing | -754.58% | 227.81% | 207.93% | 118.45% | -15.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -92.07% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 82.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 573,753.85% | -88.62% | -- | -- | 99.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.82% | 262.77% | -88.06% | 349.08% | -189.90% |